U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C20H29N3
Molecular Weight 311.4644
Optical Activity ( + / - )
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ATIPROSIN

SMILES

[H][C@]12CCN3C4=C(C=CC=C4)C(C)=C3[C@]1([H])N(CC)CCN2C(C)C

InChI

InChIKey=WXNVFYIBELASJW-AZUAARDMSA-N
InChI=1S/C20H29N3/c1-5-21-12-13-22(14(2)3)18-10-11-23-17-9-7-6-8-16(17)15(4)19(23)20(18)21/h6-9,14,18,20H,5,10-13H2,1-4H3/t18-,20+/m0/s1

HIDE SMILES / InChI

Molecular Formula C20H29N3
Molecular Weight 311.4644
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Description

Atiprosin (AY-28,228), an octahydro-pyrazino-pyrido-indole drug, possesses the alpha-adrenoceptor antagonist activity and exerts antihypertensive effects. Atiprosin has never been marketed

Approval Year

PubMed

Substance Class Chemical
Record UNII
ALS52889WF
Record Status Validated (UNII)
Record Version